These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 1720982
1. Myeloid progenitor cell growth characteristics and effect of G-CSF in a patient with congenital cyclic neutropenia. Tsunogake S, Nagashima S, Maekawa R, Takano N, Kajitani H, Saito K, Enokihara H, Furusawa S, Shishido H. Int J Hematol; 1991 Jun; 54(3):251-6. PubMed ID: 1720982 [Abstract] [Full Text] [Related]
2. Differential effects of IL-3, GM-CSF and G-CSF in an adult with congenital neutropenia. Miyachi H, Nakamura Y, Shimizu H, Watanabe K, Arimori S, Ando Y. Int J Hematol; 1992 Oct; 56(2):113-8. PubMed ID: 1384774 [Abstract] [Full Text] [Related]
3. Abnormal responses of myeloid progenitor cells to granulocyte-macrophage colony-stimulating factor in human cyclic neutropenia. Wright DG, LaRussa VF, Salvado AJ, Knight RD. J Clin Invest; 1989 Apr; 83(4):1414-8. PubMed ID: 2649515 [Abstract] [Full Text] [Related]
4. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S. Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [Abstract] [Full Text] [Related]
5. Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor. Broxmeyer HE, Benninger L, Patel SR, Benjamin RS, Vadhan-Raj S. Exp Hematol; 1994 Jan; 22(1):100-2. PubMed ID: 7506671 [Abstract] [Full Text] [Related]
6. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia. Sawai N, Koike K, Mwamtemi HH, Ito S, Kurokawa Y, Sakashita K, Kinoshita T, Higuchi T, Takeuchi K, Shiohara M, Kamijo T, Higuchi Y, Miyazaki H, Kato T, Kobayashi M, Miyake M, Yasui K, Komiyama A. J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501 [Abstract] [Full Text] [Related]
7. The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count. Cairo MS, Plunkett JM, Schendel P, van de Ven C. Exp Hematol; 1994 Oct; 22(11):1118-23. PubMed ID: 7523164 [Abstract] [Full Text] [Related]
8. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1. McCrady CW, Li F, Pettit GR, Grant S. Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503 [Abstract] [Full Text] [Related]
9. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells. Neelis KJ, Dubbelman YD, Qingliang L, Thomas GR, Eaton DL, Wagemaker G. Exp Hematol; 1997 Sep; 25(10):1084-93. PubMed ID: 9293906 [Abstract] [Full Text] [Related]
10. Hematologic effects of stem cell factor alone and in combination with G-CSF and GM-CSF in vivo and in vitro in rodents. Ulich TR, Yi ES, Yin S, del Castillo J, McNiece I, Yung YP, Zsebo KM. Int Rev Exp Pathol; 1993 Sep; 34 Pt A():215-33. PubMed ID: 7681048 [Abstract] [Full Text] [Related]
11. Effects of recombinant canine granulocyte colony-stimulating factor on white blood cell production in clinically normal and neutropenic dogs. Mishu L, Callahan G, Allebban Z, Maddux JM, Boone TC, Souza LM, Lothrop CD. J Am Vet Med Assoc; 1992 Jun 15; 200(12):1957-64. PubMed ID: 1379221 [Abstract] [Full Text] [Related]
12. Contrasting effects of recombinant human granulocyte-macrophage colony-stimulating factor (CSF) and granulocyte CSF treatment on the cycling of blood elements in childhood-onset cyclic neutropenia. Wright DG, Kenney RF, Oette DH, LaRussa VF, Boxer LA, Malech HL. Blood; 1994 Aug 15; 84(4):1257-67. PubMed ID: 7519479 [Abstract] [Full Text] [Related]
13. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors. Ottmann OG, Abboud M, Welte K, Souza LM, Pelus LM. Exp Hematol; 1989 Feb 15; 17(2):191-7. PubMed ID: 2463933 [Abstract] [Full Text] [Related]
16. Increased cytokine levels and abnormal response of myeloid progenitor cells to granulocyte colony-stimulating factor in a case of severe congenital neutropenia. In vitro effects of stem cell factor. Shitara T, Ijima H, Yugami S, Sotomatu M, Kuroume T. Am J Pediatr Hematol Oncol; 1994 May 15; 16(2):167-72. PubMed ID: 7513137 [Abstract] [Full Text] [Related]
18. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor. Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S. Exp Hematol; 1988 Aug 15; 16(7):594-602. PubMed ID: 3260558 [Abstract] [Full Text] [Related]